The Clinical Research Glossary Biannual Meeting: Adoption, Implementation, and Impact

The MRCT Center Clinical Research Glossary, a CDISC global standard since 2023, offers 216 plain-language definitions for clinical research terms used across the research enterprise.



Sylvia Baedorf Kassis, Program Director for the MRCT Center's Health Literacy portfolio, will host a conversation with a patient partner and representatives from two sponsor organizations about how the glossary is being adopted, implemented, and used in practice.

Panelists include Anna Subrizi, Patient Empowerment Team Lead at Bristol Myers Squibb; Sudipta Chakraborty, who leads the Health Literacy Center of Excellence at Biogen; and Bernard Coley, a patient partner who applies the glossary in Parkinson's disease advocacy and education work. The panel will cover how sponsors integrate the glossary across research and development, commercial, and patient-facing functions, as well as the business case for plain language and its impact within organizations and clinical research studies. 

The webinar will also feature a preview of the new terms heading into a 30-day public review this June. Public review ensures that the glossary is a living, consensus-driven CDISC global standard. Each new definition is reviewed by researchers, sponsors, patients, and advocates before adoption, so the professionals who design trials have a trusted resource to communicate with participants and help enable informed decision-making. Attendees will learn what public review entails and how to submit feedback.